116 related articles for article (PubMed ID: 486291)
1. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
Wong L; Nation RL; Chiou WL; Mehta PK
Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
[TBL] [Abstract][Full Text] [Related]
2. Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
Schneck DW; Pritchard JF; Hayes AH
Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):3-12. PubMed ID: 432438
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.
Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
Clin Pharmacol Ther; 1980 Jan; 27(1):22-31. PubMed ID: 7351114
[TBL] [Abstract][Full Text] [Related]
4. Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
Cortelli P; Sacquegna T; Albani F; Baldrati A; D'Alessandro R; Baruzzi A; Lugaresi E
Arch Neurol; 1985 Jan; 42(1):46-8. PubMed ID: 3966884
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
Hibbard DM; Peters JR; Hunninghake DB
Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
[TBL] [Abstract][Full Text] [Related]
6. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.
Garceau Y; Davis I; Hasegawa J
J Pharm Sci; 1978 Jun; 67(6):826-31. PubMed ID: 660467
[TBL] [Abstract][Full Text] [Related]
7. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
Rochester CL; Gammon DE; Shane E; Bilezikian JP
Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
Von Bahr C; Hermansson J; Tawara K
Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
Albani F; Riva R; Baldrati A; Cortelli P; Perucca E; Procaccianti G; Baruzzi A
Int J Clin Pharmacol Res; 1984; 4(1):19-23. PubMed ID: 6469429
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography.
Taburet AM; Taylor AA; Mitchell JR; Rollins DE; Pool JL
Life Sci; 1979 Jan; 24(3):209-17. PubMed ID: 423699
[No Abstract] [Full Text] [Related]
11. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.
Rosseel MT; Bogaert MG
J Pharm Sci; 1981 Jun; 70(6):688-9. PubMed ID: 7252820
[TBL] [Abstract][Full Text] [Related]
12. Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow-release propranolol administration.
Drummer OH; McNeil J; Pritchard E; Louis WJ
J Pharm Sci; 1981 Sep; 70(9):1030-2. PubMed ID: 6101148
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasma.
Miller RB
J Pharm Biomed Anal; 1991; 9(10-12):953-8. PubMed ID: 1822218
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in serum.
Abdel-Hamid ME
J Clin Pharm Ther; 1988 Jun; 13(3):183-9. PubMed ID: 3209625
[TBL] [Abstract][Full Text] [Related]
15. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
Nation RL; Peng GW; Chiou WL
J Chromatogr; 1978 May; 145(3):429-36. PubMed ID: 659528
[TBL] [Abstract][Full Text] [Related]
16. Urine and plasma propranolol.
Andreasen F; Jakobsen P; Kornerup HJ; Pedersen EB; Pedersen OL
Clin Pharmacol Ther; 1983 Jan; 33(1):10-8. PubMed ID: 6848294
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography.
Walle T; Morrison J; Walle K; Conradi E
J Chromatogr; 1975 Nov; 114(2):351-9. PubMed ID: 417
[TBL] [Abstract][Full Text] [Related]
18. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. IV. A rapid microscale method for determination of propranolol and 4-hydroxypropranolol in plasma.
Sood SP; Green VI; Mason RP
Ther Drug Monit; 1988; 10(2):224-30. PubMed ID: 3381242
[TBL] [Abstract][Full Text] [Related]
19. Determination of propranolol and 4-hydroxypropranolol in human plasma by high-performance liquid chromatography.
Fu CW; Mason WD
Analyst; 1989 Oct; 114(10):1219-23. PubMed ID: 2619067
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and clinical observations in cyanotic children on propranolol therapy.
Riopel DA; Walle T
Clin Pharmacol Ther; 1980 Dec; 28(6):743-50. PubMed ID: 7438690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
